Comments

Arcutis Biotherapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Arcutis Biotherapeutics (ARQT) operate in?

Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ARQTNASDAQ

Arcutis Biotherapeutics (ARQT) Forecast

News Earnings Arcutis Biotherapeutics (ARQT) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Arcutis Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:ARQT | Benzinga

Explore Arcutis Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ARQT.

Open	$17.13
Close	-
Volume / Avg.	260.63K / 2.30M
Day Range	$16.83 - $17.54
52 Wk Range	6.99 - 17.75
Market Cap	$2.02B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	15.7%
Days to Cover	7.06

Recent News

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

Avi Kapoor

Celsius, Lucid And Signet Are Among Top 10 Mid-Cap Gainers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio?

Top performers last week: DGNX (108.29%), NEXT (25.07%), CELH (21.60%), SIG (21.08%), NFE (20.63%), MRP (16.61%), ARQT (16.35%), LCID (15.79%), CPRX (15.27%), STNE (14.20%). Are they in your portfolio?

Lekha Gupta

What's Going On With Arcutis Biotherapeutics Stock Monday?

Arcutis shares traded higher on Monday after Health Canada approved its Zoryve cream for the treatment of mild to moderate atopic dermatitis.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$17.13
Close	-
Volume / Avg.	260.63K / 2.30M
Day Range	$16.83 - $17.54
52 Wk Range	6.99 - 17.75
Market Cap	$2.02B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	15.7%
Days to Cover	7.06

About Arcutis Biotherapeutics Inc

Sector

Health Care

Industry

Biotechnology

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patien...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arcutis Biotherapeutics (ARQT) stock?

You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.

View our list of the best stock brokerages

Who are Arcutis Biotherapeutics (ARQT) competitors?

Other companies in Arcutis Biotherapeutics’s space includes: MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA), Ascentage Pharma Group (NASDAQ:AAPG), Mesoblast (NASDAQ:MESO) and Arrowhead Pharma (NASDAQ:ARWR).

What is the forecast, or price target, for Arcutis Biotherapeutics (ARQT) stock?

Arcutis Biotherapeutics has a consensus price target of $26.45.

What is the current price for Arcutis Biotherapeutics (ARQT)?

The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $17.02 last updated March 26, 2025 at 10:07 AM EDT.

Does Arcutis Biotherapeutics (ARQT) pay a dividend?

There are no upcoming dividends for Arcutis Biotherapeutics.

When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?

Arcutis Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Arcutis Biotherapeutics (ARQT) going to split?

There is no upcoming split for Arcutis Biotherapeutics.

What sector and industry does Arcutis Biotherapeutics (ARQT) operate in?

Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.